Matches in Nanopublications for { ?s ?p "When used as monotherapy or with a sulfonylurea, metformin decreases plasma triglyceride and low-density lipoprotein (LDL) cholesterol levels by 10% to 15% (14, 90-92, 106) (Table 1), reduces postprandial hyperlipemia (14), decreases plasma free fatty acid levels, and decreases free fatty acid oxidation (14, 106, 107)." ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- _2 value "When used as monotherapy or with a sulfonylurea, metformin decreases plasma triglyceride and low-density lipoprotein (LDL) cholesterol levels by 10% to 15% (14, 90-92, 106) (Table 1), reduces postprandial hyperlipemia (14), decreases plasma free fatty acid levels, and decreases free fatty acid oxidation (14, 106, 107)." provenance.
- _2 value "When used as monotherapy or with a sulfonylurea, metformin decreases plasma triglyceride and low-density lipoprotein (LDL) cholesterol levels by 10% to 15% (14, 90-92, 106) (Table 1), reduces postprandial hyperlipemia (14), decreases plasma free fatty acid levels, and decreases free fatty acid oxidation (14, 106, 107)." provenance.